IL13 and Alzheimer disease: In summary, we demonstrate that chronic fluoxetine treatment is an effective means to reduce DNCB-induced scratching bouts, depressive/anxiety-like behaviors, skin lesions and serum IgE levels in mice model of AD, and these effects are mediated by regulating pro-inflammatory cytokines, such as IL-4 and IL-13.